Artikel
Telemonitoring of blood pressure self-measurement (BPSM) in a postmarketing surveillance study with Olmesartan: the OLMETEL study
Telemonitoring von Heimblutdruckwerten in einer Beobachtungs-Studie mit Olmesartan
Suche in Medline nach
Autoren
Veröffentlicht: | 11. November 2004 |
---|
Gliederung
Text
BPSM is increasingly used in pharmacological studies as it provides longitudinal information on the time course of blood pressure (BP) over several days and weeks. Traditional BPSM is however limited by reporting bias and data loss.
The OLMETEL study investigates the feasibility of BP-telemonitoring in previously uncontrolled hypertensives treated with Olmesartan (Olmetec®, Sankyo Pharma GmbH) over 12 weeks. Telemonitoring was performed with the Tensiophone 2 device (TP2, upper arm oscillometric device, Tensiomed Hungary).TP2 home monitors were programmed through standard phone lines and data were automatically downloaded to the remote service center.
60 patients performed morning and evening BPSM with TP2 over an average of 80 monitoring days (2.53 BP readings/day). More than 12,000 BP values were sucessfully transmitted through standard phone line and are available for statistical analysis.
Data from 49 patients over 56 days of active treatment are presented in the table: [Tab. 1]
Telemonitoring of BP is feasible in pharmacological studies and allows unbiased evaluation of the extent and onset of action of antihypertensive drugs. Further analysis of all BP data will give detailed information on morning/evening ratio of antihypertensive efficacy and onset of action of Olmesartan.